Neurocrine Intangible Assets vs Long Term Debt Total Analysis

NBIX Stock

USD 115.02 0.00 0.00%

Neurocrine Biosciences financial indicator trend analysis is infinitely more than just investigating Neurocrine Biosciences recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Neurocrine Biosciences is a good investment. Please check the relationship between Neurocrine Biosciences Intangible Assets and its Long Term Debt Total accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurocrine Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Neurocrine Stock please use our How to Invest in Neurocrine Biosciences guide.

Intangible Assets vs Long Term Debt Total

Intangible Assets vs Long Term Debt Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Neurocrine Biosciences Intangible Assets account and Long Term Debt Total. At this time, the significance of the direction appears to have pay attention.

The correlation between Neurocrine Biosciences' Intangible Assets and Long Term Debt Total is -0.79. Overlapping area represents the amount of variation of Intangible Assets that can explain the historical movement of Long Term Debt Total in the same time period over historical financial statements of Neurocrine Biosciences, assuming nothing else is changed. The correlation between historical values of Neurocrine Biosciences' Intangible Assets and Long Term Debt Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Intangible Assets of Neurocrine Biosciences are associated (or correlated) with its Long Term Debt Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt Total has no effect on the direction of Intangible Assets i.e., Neurocrine Biosciences' Intangible Assets and Long Term Debt Total go up and down completely randomly.

Correlation Coefficient

-0.79

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Intangible Assets

Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.

Long Term Debt Total

Most indicators from Neurocrine Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Neurocrine Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurocrine Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Neurocrine Stock please use our How to Invest in Neurocrine Biosciences guide.At this time, Neurocrine Biosciences' Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to rise to about 151.9 M in 2025, whereas Issuance Of Capital Stock is likely to drop slightly above 22.9 M in 2025.

Neurocrine Biosciences fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Short Term Investments	Other Liab	Other Assets
Total Assets		0.22	0.98	0.87	0.99	0.94	0.47	0.62	0.99	0.41	0.99	0.74	0.95	0.98	0.48	0.82	0.69	0.92	0.97	0.93	0.99	0.58	0.87	0.94	0.29	0.77
Short Long Term Debt Total	0.22		0.2	0.39	0.16	0.21	0.4	-0.43	0.24	0.08	0.2	0.13	0.33	0.15	0.58	0.22	0.4	0.46	0.35	0.2	0.25	0.62	0.12	0.32	0.23	0.06
Other Current Liab	0.98	0.2		0.91	0.98	0.93	0.47	0.7	0.99	0.34	0.97	0.72	0.9	0.99	0.4	0.7	0.7	0.86	0.92	0.92	0.96	0.64	0.87	0.9	0.25	0.76
Total Current Liabilities	0.87	0.39	0.91		0.85	0.77	0.63	0.49	0.92	0.27	0.84	0.5	0.87	0.89	0.48	0.53	0.84	0.81	0.88	0.76	0.89	0.85	0.77	0.89	0.27	0.61
Total Stockholder Equity	0.99	0.16	0.98	0.85		0.95	0.42	0.67	0.98	0.38	0.99	0.76	0.93	0.99	0.44	0.78	0.64	0.9	0.93	0.94	0.97	0.54	0.86	0.92	0.29	0.78
Property Plant And Equipment Net	0.94	0.21	0.93	0.77	0.95		0.45	0.71	0.94	0.22	0.97	0.91	0.82	0.94	0.27	0.78	0.65	0.8	0.89	1.0	0.89	0.56	0.74	0.84	0.3	0.66
Net Debt	0.47	0.4	0.47	0.63	0.42	0.45		0.13	0.5	-0.34	0.45	0.37	0.48	0.47	0.25	0.35	0.81	0.47	0.56	0.45	0.49	0.76	0.22	0.48	0.42	-0.1
Retained Earnings	0.62	-0.43	0.7	0.49	0.67	0.71	0.13		0.67	0.04	0.68	0.64	0.39	0.7	-0.28	0.35	0.34	0.28	0.48	0.72	0.54	0.18	0.57	0.45	0.02	0.5
Accounts Payable	0.99	0.24	0.99	0.92	0.98	0.94	0.5	0.67		0.33	0.98	0.72	0.91	0.99	0.43	0.74	0.73	0.88	0.95	0.93	0.97	0.65	0.85	0.92	0.29	0.74
Cash	0.41	0.08	0.34	0.27	0.38	0.22	-0.34	0.04	0.33		0.36	0.01	0.53	0.31	0.52	0.53	0.1	0.48	0.45	0.2	0.46	0.0	0.62	0.47	-0.25	0.83
Non Current Assets Total	0.99	0.2	0.97	0.84	0.99	0.97	0.45	0.68	0.98	0.36		0.79	0.9	0.97	0.4	0.82	0.66	0.88	0.95	0.96	0.95	0.54	0.85	0.89	0.26	0.75
Non Currrent Assets Other	0.74	0.13	0.72	0.5	0.76	0.91	0.37	0.64	0.72	0.01	0.79		0.59	0.75	0.06	0.68	0.49	0.6	0.67	0.91	0.67	0.41	0.5	0.63	0.32	0.44
Cash And Short Term Investments	0.95	0.33	0.9	0.87	0.93	0.82	0.48	0.39	0.91	0.53	0.9	0.59		0.91	0.66	0.81	0.71	0.97	0.96	0.8	0.98	0.62	0.85	0.98	0.32	0.78
Net Receivables	0.98	0.15	0.99	0.89	0.99	0.94	0.47	0.7	0.99	0.31	0.97	0.75	0.91		0.41	0.72	0.67	0.87	0.92	0.93	0.97	0.59	0.84	0.92	0.34	0.73
Common Stock Shares Outstanding	0.48	0.58	0.4	0.48	0.44	0.27	0.25	-0.28	0.43	0.52	0.4	0.06	0.66	0.41		0.45	0.29	0.74	0.53	0.25	0.55	0.37	0.44	0.59	0.36	0.44
Non Current Liabilities Total	0.82	0.22	0.7	0.53	0.78	0.78	0.35	0.35	0.74	0.53	0.82	0.68	0.81	0.72	0.45		0.54	0.8	0.87	0.77	0.8	0.3	0.71	0.75	0.21	0.68
Other Current Assets	0.69	0.4	0.7	0.84	0.64	0.65	0.81	0.34	0.73	0.1	0.66	0.49	0.71	0.67	0.29	0.54		0.62	0.79	0.64	0.72	0.9	0.51	0.76	0.17	0.36
Other Stockholder Equity	0.92	0.46	0.86	0.81	0.9	0.8	0.47	0.28	0.88	0.48	0.88	0.6	0.97	0.87	0.74	0.8	0.62		0.92	0.79	0.94	0.59	0.78	0.93	0.37	0.71
Total Liab	0.97	0.35	0.92	0.88	0.93	0.89	0.56	0.48	0.95	0.45	0.95	0.67	0.96	0.92	0.53	0.87	0.79	0.92		0.88	0.97	0.66	0.84	0.94	0.27	0.74
Property Plant And Equipment Gross	0.93	0.2	0.92	0.76	0.94	1.0	0.45	0.72	0.93	0.2	0.96	0.91	0.8	0.93	0.25	0.77	0.64	0.79	0.88		0.87	0.54	0.72	0.83	0.32	0.64
Total Current Assets	0.99	0.25	0.96	0.89	0.97	0.89	0.49	0.54	0.97	0.46	0.95	0.67	0.98	0.97	0.55	0.8	0.72	0.94	0.97	0.87		0.62	0.87	0.97	0.32	0.78
Short Term Debt	0.58	0.62	0.64	0.85	0.54	0.56	0.76	0.18	0.65	0.0	0.54	0.41	0.62	0.59	0.37	0.3	0.9	0.59	0.66	0.54	0.62		0.4	0.68	0.22	0.25
Intangible Assets	0.87	0.12	0.87	0.77	0.86	0.74	0.22	0.57	0.85	0.62	0.85	0.5	0.85	0.84	0.44	0.71	0.51	0.78	0.84	0.72	0.87	0.4		0.81	0.16	0.89
Short Term Investments	0.94	0.32	0.9	0.89	0.92	0.84	0.48	0.45	0.92	0.47	0.89	0.63	0.98	0.92	0.59	0.75	0.76	0.93	0.94	0.83	0.97	0.68	0.81		0.34	0.76
Other Liab	0.29	0.23	0.25	0.27	0.29	0.3	0.42	0.02	0.29	-0.25	0.26	0.32	0.32	0.34	0.36	0.21	0.17	0.37	0.27	0.32	0.32	0.22	0.16	0.34		-0.09
Other Assets	0.77	0.06	0.76	0.61	0.78	0.66	-0.1	0.5	0.74	0.83	0.75	0.44	0.78	0.73	0.44	0.68	0.36	0.71	0.74	0.64	0.78	0.25	0.89	0.76	-0.09

Click cells to compare fundamentals

Neurocrine Biosciences Account Relationship Matchups

Neurocrine Biosciences fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	1.7B	2.1B	2.4B	3.3B	3.7B	3.9B
Short Long Term Debt Total	412.3M	440.4M	262.9M	428.4M	455.1M	477.9M
Other Current Liab	147.1M	194.3M	292M	351.4M	397.7M	417.6M
Total Current Liabilities	186.5M	245.8M	537.7M	654.8M	507.7M	533.1M
Total Stockholder Equity	1.1B	1.4B	1.7B	2.2B	2.6B	2.7B
Property Plant And Equipment Net	127.4M	155.8M	145.6M	347.3M	592M	621.6M
Net Debt	(388.7M)	99.6M	169.4M	177.3M	222.1M	233.2M
Retained Earnings	(725.4M)	(635.8M)	(406.8M)	(157.1M)	29.2M	30.7M
Accounts Payable	39.4M	51.5M	67.3M	108.9M	110M	115.5M
Cash	801M	340.8M	262.9M	251.1M	233M	136.2M
Non Current Assets Total	718.5M	1.1B	915.2M	1.6B	2.0B	2.1B
Non Currrent Assets Other	6.4M	4.4M	25M	49.6M	755M	792.8M
Cash And Short Term Investments	801M	711.3M	989.3M	1.0B	1.1B	1.1B
Net Receivables	157.1M	185.5M	350M	439.3M	479.1M	503.1M
Common Stock Shares Outstanding	97.8M	97.9M	98.9M	101M	103.7M	63.6M
Liabilities And Stockholders Equity	1.7B	2.1B	2.4B	3.3B	3.7B	3.9B
Non Current Liabilities Total	422M	452.7M	123.2M	364.6M	621.3M	652.4M
Other Current Assets	30.1M	45.5M	79.1M	97.8M	112.1M	117.7M
Other Stockholder Equity	1.8B	2.0B	2.1B	2.4B	2.6B	2.7B
Total Liab	608.5M	698.5M	660.9M	1.0B	1.1B	1.2B
Property Plant And Equipment Gross	127.4M	155.8M	145.6M	430.3M	698.5M	733.4M
Total Current Assets	1.0B	972.8M	1.5B	1.6B	1.7B	1.8B
Accumulated Other Comprehensive Income	1.8M	(1.7M)	(7.9M)	7M	5.8M	6.1M
Short Term Debt	10.3M	16.5M	169.4M	170.1M	195.6M	205.4M
Intangible Assets	11.2M	12.5M	37.2M	35.5M	36.5M	38.3M
Short Term Investments	613.9M	370.5M	726.4M	780.5M	843.1M	885.3M
Other Liab	17.1M	9.7M	12.3M	29.7M	34.2M	24.8M
Other Assets	59.1M	674M	319.5M	330.9M	380.5M	399.6M
Long Term Debt	388.5M	408.8M	317.9M	335.1M	385.4M	404.6M
Property Plant Equipment	33.9M	41.9M	44.6M	58.6M	52.7M	55.4M
Current Deferred Revenue	(46.2M)	(10.3M)	(16.5M)	229.3M	263.7M	276.9M
Net Tangible Assets	228.1M	1.1B	1.4B	1.7B	1.9B	2.0B
Retained Earnings Total Equity	(1.1B)	(725.4M)	(635.8M)	(406.8M)	(366.1M)	(384.4M)
Capital Surpluse	1.8B	1.8B	2.0B	2.1B	2.4B	1.6B
Inventory	28M	30.5M	35.1M	38.3M	57.4M	60.3M
Non Current Liabilities Other	104.1M	117.6M	29.7M	10.3M	5.5M	5.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications

Additional Tools for Neurocrine Stock Analysis

When running Neurocrine Biosciences' price analysis, check to measure Neurocrine Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurocrine Biosciences is operating at the current time. Most of Neurocrine Biosciences' value examination focuses on studying past and present price action to predict the probability of Neurocrine Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurocrine Biosciences' price. Additionally, you may evaluate how the addition of Neurocrine Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Neurocrine Intangible Assets vs Long Term Debt Total Analysis

Intangible Assets vs Long Term Debt Total

Intangible Assets vs Long Term Debt Total Correlation Analysis

Correlation Coefficient

Intangible Assets

Long Term Debt Total

Neurocrine Biosciences fundamental ratios Correlations

Neurocrine Biosciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Neurocrine Biosciences fundamental ratios Accounts

Also Currently Popular

Additional Tools for Neurocrine Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Stockholder Equity	+ 0.99	Total Assets
Accounts Payable	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Accounts Payable	+ 0.99	Other Current Liab

Retained Earnings	- 0.43	Short Long Term Debt Total
Cash	- 0.34	Net Debt
Common Stock Shares Outstanding	- 0.28	Retained Earnings
Other Liab	- 0.25	Cash
Other Assets	- 0.1	Net Debt
Other Assets	- 0.09	Other Liab